Price | 1W % | 1M % | 3M % | 6M % | 1Y % | YTD % |
---|---|---|---|---|---|---|
-- | -- | -- | -- | -- | -- | -- |
AI Generated Qualitative Analysis
Your time is precious, so save it. Use AI to get the most important information from the business.
Learn about Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc. News
Thermo Fisher Scientific Inc. Quantitative Score
About Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.
Thermo Fisher Scientific Inc. Earnings & Revenue
Thermo Fisher Scientific Inc. Financials
Table Compare
Compare TMO metrics with: | |||
---|---|---|---|
Earnings & Growth | TMO | None | |
EPS (TTM) YoY Growth | -- | -- | |
Revenue (TTM) YoY Growth | -- | -- | |
Valuation (TTM) | TMO | None | |
Price/Earnings Ratio | -- | -- | |
Price/Sales Ratio | -- | -- | |
Profitability & Efficiency (TTM) | TMO | None | |
Net Profit Margin | -- | -- | |
Return on Equity | -- | -- | |
Financial Health (TTM) | TMO | None | |
Debt/Assets Ratio | -- | -- | |
Assets/Liabilities Ratio | -- | -- | |
Thermo Fisher Scientific Inc. Income
Thermo Fisher Scientific Inc. Balance Sheet
Thermo Fisher Scientific Inc. Cash Flow
Thermo Fisher Scientific Inc. Financials Over Time
Analysts Rating
Strong Buy
Buy
Hold
Sell
Strong Sell
Metrics Scores
Metrics | Score |
---|---|
Discounted Cash Flows | Strong Buy |
Return on Equity | Buy |
Return on Assets | Buy |
Debt/Equity Ratio | Strong Sell |
Price/Earnings Ratio | Strong Sell |
Price/Book Ratio | Strong Sell |
Price Targets
Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.
Thermo Fisher Scientific Inc. Dividends
Yield (TTM) | Dividend (TTM) | |
---|---|---|
Infinity% | 1.5200 |
Payment Date | Dividend | Frequency |
---|---|---|
2024-10-15 | 0.39 | Quarterly |
2024-07-15 | 0.39 | Quarterly |
2024-04-15 | 0.39 | Quarterly |
2024-01-16 | 0.35 | Quarterly |
2023-10-13 | 0.35 | Quarterly |
Thermo Fisher Scientific Inc. Valuation
Project future cash flows and get the intrinsic value per share.
Historical Market Cap
Shares Outstanding
Thermo Fisher Scientific Inc. Executives
Name | Role |
---|---|
Mr. Marc N. Casper | Chairman, President & Chief Executive Officer |
Mr. Michel Lagarde | Executive Vice President & Chief Operating Officer |
Mr. Stephen Williamson | Senior Vice President & Chief Financial Officer |
Mr. Michael A. Boxer Esq. | Senior Vice President & General Counsel |
Mr. Gianluca Pettiti | Executive Vice President |
Name | Role | Gender | Date of Birth | Pay |
---|---|---|---|---|
Mr. Marc N. Casper | Chairman, President & Chief Executive Officer | Male | 1968 | 5.08M |
Mr. Michel Lagarde | Executive Vice President & Chief Operating Officer | Male | 1975 | 2.22M |
Mr. Stephen Williamson | Senior Vice President & Chief Financial Officer | Male | 1967 | 2.02M |
Mr. Michael A. Boxer Esq. | Senior Vice President & General Counsel | Male | 1962 | 1.76M |
Mr. Gianluca Pettiti | Executive Vice President | Male | 1979 | 1.66M |
Thermo Fisher Scientific Inc. Insider Trades
Date | 28 Sep |
Name | WEISLER DION J |
Role | Director |
Transaction | Acquired |
Type | A-Award |
Shares | 61.03 |
Date | 28 Sep |
Name | Keith R. Alexandra |
Role | Director |
Transaction | Acquired |
Type | A-Award |
Shares | 50.86 |
Date | 28 Sep |
Name | JOHNSON JENNIFER M |
Role | Director |
Transaction | Acquired |
Type | A-Award |
Shares | 50.86 |
Date | 28 Sep |
Name | SPERLING SCOTT M |
Role | Director |
Transaction | Acquired |
Type | A-Award |
Shares | 67.14 |
Date | 4 Sep |
Name | CASPER MARC N |
Role | Chairman & CEO |
Transaction | Acquired |
Type | M-Exempt |
Shares | 10000 |
Date | Name | Role | Transaction | Type | Shares |
---|---|---|---|---|---|
28 Sep | WEISLER DION J | Director | Acquired | A-Award | 61.03 |
28 Sep | Keith R. Alexandra | Director | Acquired | A-Award | 50.86 |
28 Sep | JOHNSON JENNIFER M | Director | Acquired | A-Award | 50.86 |
28 Sep | SPERLING SCOTT M | Director | Acquired | A-Award | 67.14 |
4 Sep | CASPER MARC N | Chairman & CEO | Acquired | M-Exempt | 10000 |